Duong, H., Hong, Y. B., Kim, J. S., Lee, H., Yi, Y. W., Kim, Y. J., . . . Bae, I. (2013). Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabine. Blackwell Publishing Ltd.
Chicago Style aipamenaDuong, Hong-Quan, et al. Inhibition of Checkpoint Kinase 2 (CHK2) Enhances Sensitivity of Pancreatic Adenocarcinoma Cells to Gemcitabine. Blackwell Publishing Ltd, 2013.
MLA aipamenaDuong, Hong-Quan, et al. Inhibition of Checkpoint Kinase 2 (CHK2) Enhances Sensitivity of Pancreatic Adenocarcinoma Cells to Gemcitabine. Blackwell Publishing Ltd, 2013.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.